MQ Lacy

424 total citations
12 papers, 313 citations indexed

About

MQ Lacy is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, MQ Lacy has authored 12 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in MQ Lacy's work include Multiple Myeloma Research and Treatments (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). MQ Lacy is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). MQ Lacy collaborates with scholars based in United States and Spain. MQ Lacy's co-authors include Ayalew Tefferi, MA Gertz, MR Litzow, Angela Dispenzieri, WJ Hogan, RA Kyle, JA Lust, RA Kyle, M. A. Elliott and Shaji Kumar and has published in prestigious journals such as Blood, Leukemia and Bone Marrow Transplantation.

In The Last Decade

MQ Lacy

11 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MQ Lacy United States 9 156 102 90 68 65 12 313
RA Krance United States 8 280 1.8× 81 0.8× 67 0.7× 28 0.4× 102 1.6× 8 433
Marguerite Vignon France 10 114 0.7× 90 0.9× 68 0.8× 102 1.5× 74 1.1× 26 324
Hajime Yasuda Japan 11 93 0.6× 74 0.7× 115 1.3× 66 1.0× 111 1.7× 55 366
S. K. China 11 176 1.1× 85 0.8× 61 0.7× 46 0.7× 46 0.7× 23 337
Hayato Maruoka Japan 10 65 0.4× 54 0.5× 56 0.6× 103 1.5× 73 1.1× 35 312
Taiji Yokote Japan 10 61 0.4× 66 0.6× 61 0.7× 124 1.8× 90 1.4× 60 372
Alessandro Bucalossi Italy 11 218 1.4× 88 0.9× 160 1.8× 31 0.5× 97 1.5× 26 379
Bérengère Gruson France 10 166 1.1× 56 0.5× 101 1.1× 19 0.3× 51 0.8× 21 328
Caroline Thomas France 7 71 0.5× 83 0.8× 117 1.3× 83 1.2× 109 1.7× 7 359
Toshihiro Onishi Japan 10 196 1.3× 54 0.5× 41 0.5× 95 1.4× 98 1.5× 16 309

Countries citing papers authored by MQ Lacy

Since Specialization
Citations

This map shows the geographic impact of MQ Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MQ Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MQ Lacy more than expected).

Fields of papers citing papers by MQ Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MQ Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MQ Lacy. The network helps show where MQ Lacy may publish in the future.

Co-authorship network of co-authors of MQ Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of MQ Lacy. A scholar is included among the top collaborators of MQ Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MQ Lacy. MQ Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kapoor, Prashant, RA Kyle, S. Vincent Rajkumar, et al.. (2009). A366 Relevance of Conventional Prognostic Factors in Multiple Myeloma (MM) in the Era of Novel Therapies. Clinical Lymphoma & Myeloma. 9. S60–S60.
2.
Gertz, MA, MQ Lacy, Angela Dispenzieri, et al.. (2009). A481 Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Smoldering or Indolent Myeloma. Clinical Lymphoma & Myeloma. 9. S76–S77. 1 indexed citations
3.
Lacy, MQ, et al.. (2002). IL-1β expression in IgM monoclonal gammopathy and its relationship to multiple myeloma. Leukemia. 16(3). 382–385. 18 indexed citations
4.
Kumar, Shaji, et al.. (2001). Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease. Bone Marrow Transplantation. 27(11). 1133–1140. 8 indexed citations
5.
Hogan, WJ, et al.. (2001). Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplantation. 28(3). 305–309. 51 indexed citations
6.
Kumar, Shaji, et al.. (2001). Post-transplant complications High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. 9 indexed citations
7.
Gertz, MA, et al.. (2000). Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL). Bone Marrow Transplantation. 26(9). 963–969. 74 indexed citations
9.
Lacy, MQ, et al.. (1997). Factors influencing platelet recovery after blood cell transplantation in multiple myeloma. Bone Marrow Transplantation. 20(5). 375–380. 16 indexed citations
10.
Elliott, M. A., et al.. (1997). Disseminated nocardiosis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 20(5). 425–426. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026